Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $6.8 million.

  • TransMedics' Depreciation & Amortization (CF) rose 3229.67% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 4362.38%. This contributed to the annual value of $19.8 million for FY2024, which is 14162.9% up from last year.
  • TransMedics' Depreciation & Amortization (CF) amounted to $6.8 million in Q3 2025, which was up 3229.67% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Depreciation & Amortization (CF) ranged from a high of $6.8 million in Q3 2025 and a low of $445000.0 during Q1 2021
  • In the last 5 years, TransMedics' Depreciation & Amortization (CF) had a median value of $1.4 million in 2023 and averaged $2.8 million.
  • Per our database at Business Quant, TransMedics' Depreciation & Amortization (CF) skyrocketed by 286.98% in 2021 and then surged by 23350.25% in 2024.
  • Over the past 5 years, TransMedics' Depreciation & Amortization (CF) (Quarter) stood at $466000.0 in 2021, then skyrocketed by 175.75% to $1.3 million in 2022, then soared by 180.54% to $3.6 million in 2023, then surged by 57.56% to $5.7 million in 2024, then rose by 20.58% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, $6.7 million for Q2 2025, and $6.1 million during Q1 2025.